SCHEMBL7551708

SCHEMBL7551708

CCCCC(CCC)CCCCCCCCCCC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.50
CYP3A4 P08684 2/20 0.50
MEN1 O00255 1/20 0.50
FAAH O00519 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 2/20 0.46
TSHR P16473 2/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CA2 P00918 4/20 0.44
FFAR4 Q5NUL3 1/20 0.44
FFAR1 O14842 1/20 0.44
CA1 P00915 1/20 0.44
LMNA P02545 1/20 0.43
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9153959 0.96 ALDH1A1 (0.50) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL11080985 0.96 SOAT1 (0.53) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL28266954 0.96 ALDH1A1 (0.50) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL28231209 0.96 ALDH1A1 (0.50) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL17474426 0.92 SOAT1 (0.50) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL27753925 0.92 SOAT1 (0.59) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL25768951 0.90 CA2 (0.50) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL6143060 0.89 ALDH1A1 (0.62) MEN1KMT2AALDH1A1TSHRTDP1
SCHEMBL28269618 0.88 SOAT1 (0.46) SOAT1CYP3A4MEN1FAAHTP53
SCHEMBL11663150 0.88 CA2 (0.58) SOAT1CYP3A4MEN1FAAHTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020042445-A1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain D-PHARM LTD. (IL) 2002-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042445-A1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain OPRL1, ELOVL5, ELOVL1 SOAT1 1301/4885CYP3A4 2067/4885MEN1 4670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.